Virta Health
Virta delivers a continuous remote-care treatment that combines personalized nutrition therapy, AI and data tools, physician oversight and human health coaching. The aim is to reverse type 2 diabetes and reduce reliance on medications such as insulin. It sells mainly B2B to large employers, payers and pharmacy benefit managers, often on performance-based contracts tied to outcomes and cost savings. In June 2026 it expanded GLP-1 medication fulfillment options for employers. Its last major round was a $133M Series E in 2021 at a $2B valuation, and total funding is reported at roughly $370M–$400M depending on the source.
Funding
Every round, secondary, debt facility or acquisition involving Virta Health that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in